$1,189 – $1,289

15th Congress on Pathology and Cancer Research(CSE)

Event Information

Share this event

Date and Time

Location

Location

Vancouver

Vancouver, BC

Canada

View Map

Event description

Description

About Conference

The 15th International Congress on Pathology & Cancer Research is to be held at Vancouver, Canada during June 25-26, 2018 hosted by Conferences Series LLC. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium pathology analysis, leading universities and Cancer Research analysis establishments creating the conference an ideal platform to share expertise in Pathology, Cancer Research and related fields.

Pathology is a major field in modern medical practice and diagnosis. The global digital pathology market, valued at $1.98 billion in 2012, is estimated to reach $5.7 billion by 2020. The In vitro diagnostics market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. Diagnostic Medicine has $35 billion market, growth 5-7% yearly. Pathology labs will take approximately $15-16 billion in revenue, and they will spend roughly 12% of their revenues with their suppliers all over USA.

Cancer research ranges from epidemiology, molecular bioscience to the performance of clinical trials to evaluate and compare applications of the various cancer treatments. These applications include surgery, radiation therapy, chemotherapy, hormone therapy, immunotherapy and combined treatment modalities such as chemo-radiotherapy.

Who Should Attend?

Pathologists, Cancer Researchers, Oncologists, Cancer Pharmacologists, Cancer Therapists, Clinical Pathologists, Surgical Pathologists, pathologist in training and other healthcare professionals interested in the latest advances and techniques in the field. Another segment of target audience is Pharmaceutical researchers, Clinical organizations, Educational institutes. Anatomical Pathologists, Forensic Pathologists etc.,

The 15th International Congress on Pathology & Cancer Research will exhibit the products and services from commercial and non-commercial organizations like Pathology Lab Equipment manufacturers, Cell Diagnostics laboratories, Clinical Trial Sites, Business delegates and Equipment Manufacturers.

Why to attend Pathology and Cancer Research 2018?

  • Best platform to develop new partnership & collaborations.
  • Best location to speed up your route into every territory in the World.
  • 89% our conference attendees are the Key contact in their labs purchasing decisions.
  • Our exhibitor booths were visited 4-5 times by 80% of the attendees during the conference.
  • Past exhibitor’s feedback reveals ample of enquiries perceived from the conference attendees.
  • Network development with both Academia and Business.

Pathology and Cancer Research 2018 is going to be held at Vancouver, Canada during June 25-26, 2018. The conference is organized with the theme "Shaping the Future for the Betterment of Human Health" which comprised of 22 sessions/tracks designed to offer comprehensive sessions that address current issues in this field.

Pathology is a branch of medical science primarily concerning the examination of organs, tissues, and bodily fluids in order to make a diagnosis of disease. Pathology is a major field in modern medical practice and health care. Pathology outlines the disease condition and treatment by using different pathology laboratory techniques. Pathology is used in the diagnosis, treatment and management of an increasing range of clinical conditions. Pathology investigations are an integral part of the clinical consultation and procedural process with overseas studies indicating that 70-80 per cent of all health care decisions affecting diagnosis or treatment involve a pathology investigation. 40% of pathology testing is used for diagnostic purposes, 40% for monitoring and 20% for preventative purposes.

The dominance of the North American market can be attributed to the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada.

Market Analysis


Market Analysis of Pathology

The global digital pathology market, valued at $1.98 billion in 2012, is estimated to reach $5.7 billion by 2020. The In vitro diagnostics market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. Diagnostic Medicine has $35 billion market, growth 5-7% yearly. Pathology labs will take approximately $15-16 billion in revenue, and they will spend roughly 12% of their revenues with their suppliers all over USA.

Overall Statistics

  • Over 7000 licenses have been issued to pathology labs in the US
  1. 1,600-1,700 commercial labs
  2. 3,300-3,400 hospital labs
  3. 1,800-1,900 physicians’ office labs
  • Academic department in U.S. (130 medical schools; 155 training programs)
  • 59 Universities are there in USA
  • 36 Societies and Association

Market analysis of Cancer:

Cancer Market Study:

Global Oncology/Cancer Drugs Market is expected to garner $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Immunotherapies/ biologics are emerging as potential therapies to find the permanent cure for various cancer types. Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their high efficacy.

Global cancer drugs market accounted for $78,238.9 million in 2015. The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilars. However, the high cost of drug development, the threat of failure and the adverse effects of cancer drug therapy, particularly chemotherapy, hinders the market growth. Developed nations have implemented strict regulations for the design and development of cancer drugs. USFDA and European Union have undertaken significant initiatives to fuel the growth of the cancer drugs market by providing pre-market approval for potential drugs under clinical development. Asia-Pacific and LAMEA are promising regions for conducting clinical trials due a large population base and the low cost of clinical trials as compared to North America and Europe. Nevertheless, advancement of cancer drug research owing to biological/targeted therapies and personalized medicines hold promising opportunities for pharmaceutical, bio-pharmaceutical and biotechnology companies engaged in developing cancer drugs.


Past Conference Report

Pathology 2017

Pathology 2017 Report

We gratefully thank all our wonderful speakers, conference attendees, students, associations and exhibitors for making Pathology 2017 Conference the best ever!

In 2017, the conference took a new direction, broadening its focus beyond the laboratories to cover all aspects of Pathology. This has provided a unique opportunity for academic and Laboratory-wide communication and collaboration and has positioned the conference as annual conference series clinical premier event.

The 13th International Conference on Pathology, hosted by the Conference Series, LLC was held during June 26-27, 2017 at Hilton San Diego Mission Valley, San Diego, California USA, based on the theme “Shaping the Future for Innovations in Pathology and molecular diagnosis". Conference series will acknowledge with gratitude the support by all the Editorial Board Members of Journal of Clinical & Experimental Pathology and Journal of Molecular Diagnostics for their valuable suggestions for up growth of the Organization

The conference was initiated with the Honorable presence of the Keynote forum. The list includes:

  • Shahla Masood, University of Florida, USA
  • Dale D Tang, Albany Medical College, USA
  • Robert H Schiestl, University of California, USA

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Anatomical Pathology
  • Clinical Pathology
  • Dermatopathology
  • Renal Pathology
  • Oral and Maxillofacial Pathology
  • Forensic Pathology
  • Veterinary Pathology
  • e-Pathology
  • Molecular Pathology
  • Surgical Pathology

SPEAKERS

Shahla Masood

Shahla Masood

Professor, University of Florida USA

Dale D Tang

Dale D Tang

Professor, Albany Medical College USA

Robert H Schiestl

Robert H Schiestl

Professor, University of California USA

Ian Macreadie

Ian Macreadie

Associate Professor, RMIT University Australia

Bharat Thyagarajan

Bharat Thyagarajan

Associate Professor, University of Minnesota USA

Clay J Cockerell

Clay J Cockerell

Cockerell Dermatopathology USA

John E Tomaszewski

John E Tomaszewski

Professor, State University of New York at the University at Buffalo USA

Jason X Cheng

Jason X Cheng

University of Chicago USA

Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:

- Multiple participant discounts

- Price quotations or visa invitation letters

- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)

- Event sponsorship

NO REFUNDS ALLOWED ON REGISTRATIONS

Prices may go up any time. Service fees included in pricing.

-----------------------------------------------------------------

This event is brought to you by:

Conferenceseries Ltd. - NewYorkEventsList

http://www.NyEventsList.com

http://www.BostonEventsList.com

http://www.SFBayEventsList.com

-----------------------------------------------------------------

SHU180112CEV

Share with friends

Date and Time

Location

Vancouver

Vancouver, BC

Canada

View Map

Save This Event

Event Saved